Luke Dow, PhD, discusses the next steps for researching the Wnt pathway in colorectal cancer.
Luke Dow, PhD
Advertisement
Articles by Luke Dow, PhD
Luke Dow, PhD, discusses phase I trials targeting the Wnt signaling pathway in colorectal cancer.
Advertisement
Latest Updated Articles
Targeting Wnt in BRAF-Mutant Colorectal CancerPublished: October 28th 2019 | Updated:
Next Steps for Wnt Research in Colorectal CancerPublished: December 6th 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Approves Larger Vial Size for Nelarabine Injection in T-ALL and T-LBL
5